BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $4.11 | Prev. Close $4.15 | Circuit Range N/A |
Day Range $4.11 - $4.11 | Year Range $0.61 - $13.78 | Volume 418 |
Average Traded $4.11 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $4.28 | $4.17 | -3.70% |
03-Feb-26 | $4.34 | $4.33 | -2.15% |
02-Feb-26 | $4.28 | $4.42 | +2.79% |
30-Jan-26 | $4.29 | $4.30 | +0.12% |
29-Jan-26 | $4.41 | $4.30 | -7.63% |
28-Jan-26 | $4.95 | $4.66 | -5.39% |
27-Jan-26 | $4.64 | $4.92 | +5.13% |